Compare drug alternatives
Ajovy® Alternatives
Ajovy®
(Fremanezumab)
Ajovy
-
Migraine
- Emgality®
- Aimovig®
- Nurtec ODT®
- Ubrelvy®
- Qulipta®
Prescription Only
Ajovy is a prescription medication that can be self-injected once a month or once every three months under the skin to prevent migraine headaches. The most commonly reported side effect is injection site reactions. Ajovy does not seem to cause constipation. Additionally, there are no known drug interactions.
Ajovy is FDA approved for the following indications: Migraine prevention.
Vyepti®
(eptinezumab-jjmr)
Vyepti
-
Migraine
- Emgality®
- Aimovig®
- Nurtec ODT®
- Ubrelvy®
- Qulipta®
Prescription Only
Vypeti is a prescription medication used for migraine prevention. It is administered as an intravenous infusion four times a year. The most common reported side effects were stuffy nose and scratchy throat.
Vyepti is FDA approved for the following indications: Migraine prevention.
Dosage & Administration
Administration
Subcutaneous
Intravenous infusion (must be diluted)
Dosing
225 mg monthly or 675 mg every 3 months (as three consecutive injections of 225 mg each)
100 mg every 3 months or 300 mg (for some patients)
Latin Shorthand
225 mg/mo or 675 mg q3mo
100 mg q3mo
Financial Assistance
Copay
$5
$0
Annual Cap
Patient specific maximum benefit.
$200 per infusion for administration costs
Assistance Expiration
12/31/2023
Calendar year
Generics
No lower-cost generic available
No lower-cost generic available